RFP QuestBeta
OpenStage · tender 31 days to close

Natural England

Exposure and Effects of Veterinary Medicines and Pesticides to Aquatic Wildlife in Protected Sites.

R&DCPV 73000000
Value£42k
Deadline21 Aug 2026
Published22 Jul 2026
RegionNationwide
Timeline
Published 22 Jul 202631 days leftCloses 21 Aug 2026
Who to contact
Philip.Thorpe@naturalengland.org.uk

The procurement contact named on the official notice.

How to submit

To apply for this opportunity you must submit your quotation meeting the requirements detailed in the Request for Quotation (RFQ) attached. Your response must be sent to Philip.Thorpe@naturalengland.org.uk by 17:00 on Friday 21st August 2026. If you have any clarification questions linked to this opportunity or the procurement process please submit these via email to Philip.Thorpe@naturalengland.org.uk. Please note that, unless commercially sensitive, both the question and the response will be circulated to all tenderers.

The submission route named on the official notice.

Contract value in context
£42ktotal contract value
median £66k
this tender£0£561k

This sits in the lower-middle of the Research & Development band — a mid-scale opportunity. Based on 20,405 valued Research & Development tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

Passive quantitative sampling methodology will be employed to allow the full picture of chemical exposure to wildlife to be assessed.

Chemical analysis would be selective to chemicals most relevant to remain cost effective.

Based on the above analysis, evidence of exposure above the regulatory acceptable concentrations (RAC) for each substance can be used to assess the potential for adverse effects on aquatic species.

Furthermore, the additive or synergistic adverse effects of chemical mixtures can be assessed.

The evidence of effects from the risk assessment evidence may allow direct management practices to mitigate the adverse effects of these chemicals, either at source, in wastewater treatment works or at the protected site.

This work is designed to provide evidence to Natural England, Pharmaceuticals in the Environment Group and DEFRA Biodiversity Pressures Team.

Key requirements

What the supplier must deliver

01

This work is designed to provide evidence

This work is designed to provide evidence to Natural England, Pharmaceuticals in the Environment Group and DEFRA Biodiversity Pressures Team.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at Natural England, and generate a go-to-market strategy from their news, accounts and people.

Deep dive · beta

The full intelligence dossier

Our agent reads Natural England’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.

Source & provenance
OCID
ocds-h6vhtk-06d059
Stage
tender · Open
Source
Find a Tender
Buyer ref
068925-2026
View the original notice on Find a Tender

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Research & Development

Scroll to explore the market network

Natural England’s tender network

Assembling the network…

Also open now

Similar open tenders

Medicines Licensing Assessor Services

MHRA

Closes 6 Aug 2026Healthcare
£10.0mValue